Active Surveillance May Be the Best Initial Management for Papillary Thyroid Microcarcinoma

Active surveillance for low-risk papillary thyroid microcarcinoma (PTMC; T1aN0MI) was initiated at Kuma Hospital (Kobe, Japan) in 1993, based on a proposal by Akira Miyauchi. Favorable outcomes of such surveillance have been reported. Our latest study revealed 5- and 10-year tumor enlargement rates...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Yasuhiro, Miyauchi, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243838/
https://www.ncbi.nlm.nih.gov/pubmed/37287648
http://dx.doi.org/10.1210/jendso/bvad063
_version_ 1785054510504214528
author Ito, Yasuhiro
Miyauchi, Akira
author_facet Ito, Yasuhiro
Miyauchi, Akira
author_sort Ito, Yasuhiro
collection PubMed
description Active surveillance for low-risk papillary thyroid microcarcinoma (PTMC; T1aN0MI) was initiated at Kuma Hospital (Kobe, Japan) in 1993, based on a proposal by Akira Miyauchi. Favorable outcomes of such surveillance have been reported. Our latest study revealed 5- and 10-year tumor enlargement rates (by ≥ 3 mm) of 3.0% and 5.5% and 5- and 10-year node metastasis appearance rates of 0.9% and 1.1%, respectively. The postoperative prognosis did not differ between patients who underwent immediate surgery and those who underwent conversion surgery after progression. These findings suggest that active surveillance may be the best initial management of PTMCs.
format Online
Article
Text
id pubmed-10243838
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-102438382023-06-07 Active Surveillance May Be the Best Initial Management for Papillary Thyroid Microcarcinoma Ito, Yasuhiro Miyauchi, Akira J Endocr Soc Perspective Active surveillance for low-risk papillary thyroid microcarcinoma (PTMC; T1aN0MI) was initiated at Kuma Hospital (Kobe, Japan) in 1993, based on a proposal by Akira Miyauchi. Favorable outcomes of such surveillance have been reported. Our latest study revealed 5- and 10-year tumor enlargement rates (by ≥ 3 mm) of 3.0% and 5.5% and 5- and 10-year node metastasis appearance rates of 0.9% and 1.1%, respectively. The postoperative prognosis did not differ between patients who underwent immediate surgery and those who underwent conversion surgery after progression. These findings suggest that active surveillance may be the best initial management of PTMCs. Oxford University Press 2023-05-16 /pmc/articles/PMC10243838/ /pubmed/37287648 http://dx.doi.org/10.1210/jendso/bvad063 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Perspective
Ito, Yasuhiro
Miyauchi, Akira
Active Surveillance May Be the Best Initial Management for Papillary Thyroid Microcarcinoma
title Active Surveillance May Be the Best Initial Management for Papillary Thyroid Microcarcinoma
title_full Active Surveillance May Be the Best Initial Management for Papillary Thyroid Microcarcinoma
title_fullStr Active Surveillance May Be the Best Initial Management for Papillary Thyroid Microcarcinoma
title_full_unstemmed Active Surveillance May Be the Best Initial Management for Papillary Thyroid Microcarcinoma
title_short Active Surveillance May Be the Best Initial Management for Papillary Thyroid Microcarcinoma
title_sort active surveillance may be the best initial management for papillary thyroid microcarcinoma
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243838/
https://www.ncbi.nlm.nih.gov/pubmed/37287648
http://dx.doi.org/10.1210/jendso/bvad063
work_keys_str_mv AT itoyasuhiro activesurveillancemaybethebestinitialmanagementforpapillarythyroidmicrocarcinoma
AT miyauchiakira activesurveillancemaybethebestinitialmanagementforpapillarythyroidmicrocarcinoma

Ejemplares similares